Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Cure8 research brief
Why This Matters
This study links bile-acid signaling through FXR in dendritic cells to regulation of Tph cells, a T-cell subset found in IBD. Understanding these immune pathways could point to new biological mechanisms relevant to inflammation in Crohn’s disease and ulcerative colitis.
Who Should Pay Attention
Researchers studying IBD immunology, clinicians interested in emerging mechanistic research, and translational scientists exploring FXR or dendritic-cell–targeted approaches.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This abstract reports a basic-science study examining how the farnesoid X receptor (FXR) in dendritic cells affects differentiation of peripheral helper T (Tph) cells in models of intestinal inflammation.
The authors used human tissue staining and mouse experiments (including FXR-deficient mice and treatment with the FXR agonist obeticholic acid) plus in vitro cultures of bone-marrow-derived dendritic cells to study effects on DC maturation, IL-12 production, PPAR-γ signaling, and Tph cell induction.
Key findings presented: Tph cells were elevated in inflamed intestinal tissue; activating FXR with obeticholic acid increased Tph proportions in wild-type mice; FXR deficiency reduced DC maturation markers (CD11c, MHC-II), lowered IL-12 secretion, activated PPAR-γ signaling, and impaired DC-driven Tph differentiation in vitro.
These points are taken from the article abstract (structured content depth: abstract) and summarize the experimental observations without implying clinical benefit or therapeutic recommendations.
Keep In Mind
This is a laboratory and animal-model–focused study reported as an abstract on PubMed (structured-content depth: abstract). It does not provide clinical trial data or patient outcomes; findings in mice and in vitro systems may not translate directly to human treatments.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInflammation research : official journal of the European Histamine Research Society ... [et al.]
AuthorsZhen Hu, Minya Liu, Chengkai Zhu +5 more
InstitutionDepartment of Gastroenterology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, No.321 Zhongshan Road, Gulou District, Nanjing, 210008, Jiangsu, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedJul 31, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declarations. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose. Ethical approval: The study protocol was approved by the Ethics Committee of Nanjing General Hospital of Nanjing Military Command (2022DZKY-048-01). Informed consent was obtained from all individual participants included in the study. All experimental procedures involving animals were approved by the Animal Ethics Committee of Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University (2024AE01064). Consent to participate: Informed consent was obtained from all individual participants included in the study.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Sutterella Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation byspecies.
Researchers identify a gut microbe (Sutterella species) that may worsen intestinal inflammation by blocking AhR-driven IL-22 and IL-17 responses—pathways that help protect the gut lining.
Influence of the absence of TRPM5 in CD4 T cells during the inflammatory response in autoimmune colitis induced by adoptive cell transfer 2258085
The study identifies TRPM5 in CD4 T cells as a modulator of T cell activation and intestinal inflammation in a mouse colitis model, which could help researchers exploring new immune-pathway targets for IBD.
Microbial metabolite hyodeoxycholic acid induces macrophage immunometabolic reprogramming and alleviates ulcerative colitis.
The work links a missing bacterial metabolite (HDCA) to macrophage metabolism and reduced intestinal inflammation in experimental models, highlighting a potential microbiome-derived pathway that could be targeted for...